- Home
- EMX vs HRTX Comparison
EMX vs HRTX Comparison
Compare EMX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMX
- HRTX
- Stock Information
- Founded
- EMX N/A
- HRTX 1983
- Country
- EMX Canada
- HRTX United States
- Employees
- EMX N/A
- HRTX N/A
- Industry
- EMX
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- EMX
- HRTX Health Care
- Exchange
- EMX Nasdaq
- HRTX Nasdaq
- Market Cap
- EMX 196.2M
- HRTX 229.7M
- IPO Year
- EMX N/A
- HRTX 1987
- Fundamental
- Price
- EMX $1.70
- HRTX $1.63
- Analyst Decision
- EMX Strong Buy
- HRTX Strong Buy
- Analyst Count
- EMX 1
- HRTX 3
- Target Price
- EMX $7.00
- HRTX $5.67
- AVG Volume (30 Days)
- EMX 287.5K
- HRTX 1.6M
- Earning Date
- EMX 11-07-2024
- HRTX 03-11-2025
- Dividend Yield
- EMX N/A
- HRTX N/A
- EPS Growth
- EMX N/A
- HRTX N/A
- EPS
- EMX N/A
- HRTX N/A
- Revenue
- EMX $26,818,000.00
- HRTX $137,737,000.00
- Revenue This Year
- EMX N/A
- HRTX $13.10
- Revenue Next Year
- EMX $2.34
- HRTX $18.76
- P/E Ratio
- EMX N/A
- HRTX N/A
- Revenue Growth
- EMX 25.53
- HRTX 12.13
- 52 Week Low
- EMX $1.41
- HRTX $1.04
- 52 Week High
- EMX $2.15
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- EMX 46.20
- HRTX 53.73
- Support Level
- EMX $1.69
- HRTX $1.46
- Resistance Level
- EMX $1.74
- HRTX $1.58
- Average True Range (ATR)
- EMX 0.04
- HRTX 0.10
- MACD
- EMX -0.00
- HRTX -0.01
- Stochastic Oscillator
- EMX 21.43
- HRTX 45.95
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco, and Australia.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.